grade 2 follicular lymphoma ( fuh-LIH-kyoo-ler lim-FOH-muh) An indolent (slow-growing) type of non-Hodgkin lymphoma marked by enlarged lymph nodes and a mix of large cells and small cells that have cleaved (u-shaped) nuclei.
Also, what is the survival rate for follicular lymphoma?
Below are the 5-year relative survival rates for two common types of NHL - diffuse large B-cell lymphoma and follicular lymphoma - based on people diagnosed between 2009 and 2015.
5-year relative survival rates for NHL.
|SEER Stage ||5-Year Relative Survival Rate |
|Distant ||55% |
|All SEER stages combined ||63% |
Beside above, does follicular lymphoma spread?
Follicular lymphoma. It is a very slow-growing type of non-Hodgkin lymphoma that begins in B lymphocytes. It affects the lymph nodes and may spread to the bone marrow or spleen. Most patients with follicular lymphoma are age 50 years and older when they are diagnosed. Follicular lymphoma may go away without treatment.
Is follicular lymphoma deadly?
Follicular lymphoma (FL) is typically a slow-growing or indolent form of non- Hodgkin lymphoma (NHL) that arises from B-lymphocytes, making it a B-cell lymphoma. Follicular lymphoma is usually not considered to be curable, but more of a chronic disease. Patients can live for many years with this form of lymphoma.
What is the best treatment for follicular lymphoma?
Rituxan (rituximab), an intravenous anti-CD20 monoclonal antibody, is approved, in combination with chemotherapy, as a first-line treatment for follicular lymphoma. The addition of Rituxan to chemotherapy as first-line therapy has been shown to extend patients' survival by 2 years or more.